These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. Hack N; Akbar U; Thompson-Avila A; Fayad SM; Hastings EM; Moro E; Nestor K; Ward H; York M; Okun MS J Parkinsons Dis; 2014; 4(4):591-8. PubMed ID: 25035311 [TBL] [Abstract][Full Text] [Related]
12. Introduction to Parkinson disease (PD) and its complications. Marvanova M Ment Health Clin; 2016 Sep; 6(5):229-235. PubMed ID: 29955475 [TBL] [Abstract][Full Text] [Related]
13. Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists. Mohammad ME; Vizcarra JA; Garcia X; Patel S; Margolius A; Yu XX; Fernandez HH Clin Park Relat Disord; 2021; 4():100091. PubMed ID: 34316669 [TBL] [Abstract][Full Text] [Related]
15. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105 [TBL] [Abstract][Full Text] [Related]
16. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients]. Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474 [TBL] [Abstract][Full Text] [Related]
17. Impulse Control and Related Disorders in Parkinson's Disease. Weintraub D; Claassen DO Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938 [TBL] [Abstract][Full Text] [Related]
18. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J; J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296 [TBL] [Abstract][Full Text] [Related]
19. Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease. Picillo M; Phokaewvarangkul O; Poon YY; McIntyre CC; Beylergil SB; Munhoz RP; Kalia SK; Hodaie M; Lozano AM; Fasano A Mov Disord; 2021 Mar; 36(3):672-680. PubMed ID: 33165964 [TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease management and impulse control disorders: current state and future perspectives. Vitale C; Amboni M; Erro R; Picillo M; Pellecchia MT; Barone P; Trojano L; Santangelo G Expert Rev Neurother; 2019 Jun; 19(6):495-508. PubMed ID: 31148487 [No Abstract] [Full Text] [Related] [Next] [New Search]